Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
26.0%
% of FTXH's 51 holdings also in PPH
56.5%
% of PPH's 26 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 8.1% | 7.2% | 7.2% |
|
ABBVIE INC | 7.0% | 6.3% | 6.3% |
|
MERCK & CO. INC. | 7.1% | 4.8% | 4.8% |
|
PFIZER INC | 7.1% | 4.4% | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% | 4.2% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PPH
|
GILEAD SCIENCES INC | 3.9% |
|
AMGEN INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
BIOGEN IDEC INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% |
|
PFIZER INC | 2.6% |
|
MERCK & CO. INC. | 2.4% |
|
EXELIXIS INC | 2.1% |
|
MEDPACE HOLDINGS, INC. | 1.9% |
FTXH Underweight Relative to PPH
|
ELI LILLY & CO | -9.9% |
 |
NOVARTIS AG-ADR | -5.8% |
|
CENCORA INC | -5.8% |
|
MCKESSON CORP | -5.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -5.1% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.3% |